Hyperbaric oxygen therapy mediates increased... (2007 study) Skip to main content
Clinical Trial Adv Skin Wound Care 2007

Hyperbaric oxygen therapy mediates increased nitric oxide production associated with wound healing: a preliminary study

Boykin J, Baylis C, Adv Skin Wound Care, 2007

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers measured nitric oxide (NO) related markers in the wound fluid and blood of 6 people with chronic wounds who responded well to hyperbaric oxygen therapy (HBOT).

What They Found

This preliminary study of 6 chronic wound patients who responded favorably to HBOT found that wound fluid nitrate and nitrite (NOx), the stable products of nitric oxide, were significantly elevated at 1 and 4 weeks after therapy. The treatment was 20 sessions at 2.0 ATA for 90 minutes. Wound fluid NOx tended to increase during treatments, and the levels correlated with reductions in wound area. Blood plasma L-arginine and asymmetric dimethylarginine (ADMA) did not change during or after HBOT. The abstract states that successful HBOT was associated with more granulation tissue and significantly improved wound closure.

What This Means for Canadian Patients

For people with chronic wounds, this small study looked only at patients who had already done well with HBOT. It suggests that higher nitric oxide levels in the wound may be one factor linked to healing, but it did not compare these patients with others. It does not show that HBOT caused the changes in nitric oxide or in wound healing.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study was preliminary, included only 6 patients who had already responded favorably to HBOT, and had no comparison group, so it cannot show that HBOT caused the nitric oxide changes or the healing.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Trial
Category Wound Care
Source Pubmed
PubMed ID 17620739
Year Published 2007
Journal Adv Skin Wound Care
MeSH Terms Arginine; Chromatography, High Pressure Liquid; Chronic Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Exudates and Transudates; Fasting; Female; Granulation Tissue; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Nitric Oxide; Oxidation-Reduction; Time Factors; Treatment Outcome; Wound Healing; Wounds and Injuries

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology